Medical Pot Firm Developed A Drug NFL Players’ Protection

We’ve taken the preclinical approach so far to date on our first indication which is hepatic encephylopathy, which is a brain-liver disorder, where you do have neuronal degradation and degeneration, oxidative stress, Dean Petkanas, CEO of KannaLife Sciences told Foxiness.com. So we felt that we could look at that in parallel with chronic traumatic encephylopathy, (CTE) another brain-related disease, and see if neuroprotection would indeed be afforded across that panel.

The condition garnered national attention with a rash of suicides in retired National Football League (NFL) players who were suffering from symptoms similar to those seen in patients with Alzheimer’s, or other neurodegenerative diseases. To date, more than 4,500 retired players have filed suit against the NFL claiming that the league downplayed, dismissed and even covered up knowledge of the long-term neurological damage associated with repetitive concussions.

To read more, visit http://www.myfoxmemphis.com/story/27358956/medical-marijuana-company-developing-drug-to-protect-nfl-players-brains

Posted in: News

Comments are closed.